Last reviewed · How we verify

NCT03401775

Evaluation of the Effects of the New Program for Cognitive Enhancement and Improvement in the Elderly

Completed NA Last updated 17 January 2018
What this trial tests

NA trial testing Cognitive rehabilitation program in Aging in 40 participants. Completed in 15 December 2016.

Timeline
23 December 2015
Primary endpoint
15 December 2016
15 December 2016

Quick facts

Lead sponsorSamsung Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment40
Start date23 December 2015
Primary completion15 December 2016
Estimated completion15 December 2016
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Samsung Medical Center

Who can join

Adults 55 to 85, any sex, with Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the effect of cognitive rehabilitation program on the improvement of cognitive functions in normal elderly subjects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Cognitive rehabilitation program

Trials testing the same drug.

Other recruiting trials for Aging

Currently open trials in the same condition.

Other Samsung Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03401775.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing